Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Understanding the host genetics of chronic hepatitis B and C.

Thursz M, Yee L, Khakoo S.

Semin Liver Dis. 2011 May;31(2):115-27. doi: 10.1055/s-0031-1276642. Epub 2011 May 2. Review.

PMID:
21538279
2.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Hepatol. 2011 Apr;54(4):716-22. doi: 10.1016/j.jhep.2010.07.019. Epub 2010 Sep 19.

PMID:
21146242
3.

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

Lin CL, Kao JH.

J Biomed Sci. 2008 Mar;15(2):137-45. Epub 2007 Dec 5. Review.

PMID:
18058038
4.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
5.

The clinical implications of hepatitis B virus genotype: Recent advances.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30. doi: 10.1111/j.1440-1746.2010.06541.x. Review.

PMID:
21199523
6.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
7.

Genetic susceptibility in chronic viral hepatitis.

Thursz M.

Antiviral Res. 2001 Nov;52(2):113-6. Review.

PMID:
11672820
8.

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, Hiraga N, Kawakami Y, Aimitsu S, Kao JH, Kubo M, Tsunoda T, Kumada H, Nakamura Y, Hayes CN, Chayama K.

J Gen Virol. 2011 May;92(Pt 5):1071-81. doi: 10.1099/vir.0.029124-0. Epub 2011 Jan 12.

PMID:
21228123
9.
10.

The influence of the human genome on chronic viral hepatitis outcome.

de Andrade DR Jr, de Andrade DR.

Rev Inst Med Trop Sao Paulo. 2004 May-Jun;46(3):119-26. Epub 2004 Jul 20. Review.

11.

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T.

Gut. 1999 Aug;45(2):284-8.

12.

IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies.

Clark PJ, Thompson AJ, McHutchison JG.

Am J Gastroenterol. 2011 Jan;106(1):38-45. doi: 10.1038/ajg.2010.370. Epub 2010 Oct 5. Review.

PMID:
20924369
13.

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

Asselah T, Bièche I, Paradis V, Bedossa P, Vidaud M, Marcellin P.

Semin Liver Dis. 2007 Feb;27(1):13-27. Review.

PMID:
17295174
14.
15.

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

Ann Intern Med. 2007 May 1;146(9):649-56.

PMID:
17470833
16.

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.

Wang FS, Zhang Z.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):499-512. doi: 10.1586/egh.09.50. Review.

PMID:
19817672
17.

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, Chen DS.

Liver Int. 2007 Sep;27(7):983-8.

PMID:
17696938
18.

Viral hepatitis: human genes that limit infection.

Grünhage F, Nattermann J.

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):709-23. doi: 10.1016/j.bpg.2010.07.009. Review.

PMID:
20955972
19.
20.

Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.

Dore MP, Realdi G, Mura D, Onida A, Massarelli G, Dettori G, Graham DY, Sepulveda AR.

Hum Pathol. 2001 Jul;32(7):698-703.

PMID:
11486168

Supplemental Content

Support Center